Managing hospitalized patients with a COPD exacerbation: the role of hospitalists and the multidisciplinary team

References

• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstuctive pulmonary disease (2021 report). 2021 cited Jan 26 2021. https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf
   Google Scholar
• American Lung Association. How serious is COPD. 2019 cited Jan 26 2021. https://www.lung.org/lung-health-and-diseases/lung-disease-lookup/copd/learn-about-copd/how-serious-is-copd.html
   Google Scholar
• World Health Organization. COPD predicted to be third leading cause of death in 2030. 2008 cited Jan 26 2021. https://www.who.int/respiratory/copd/World_Health_Statistics_2008/en/
   Google Scholar
• Centers for Disease Control and Prevention. National Vital Statistics Reports. Final Data for 2017, cited January 26 2021. https://www.cdc.gov/nchs/data/nvsr/nvsr68/nvsr68_09-508.pdf
   Google Scholar
• Centers for Disease Control and Prevention. COPD. cited Jan 26 2021. https://www.cdc.gov/dotw/copd/index.html
   Google Scholar
• Mathers C, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442.
   PubMed Web of Science ®Google Scholar
• Kohansal R, Martinez-Camblor P, Agustí A, et al. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med. 2009;180(1):3–10.
   PubMed Web of Science ®Google Scholar
• Eisner M, Anthonisen N, Coultas D, et al. An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;182(5):693–718.
   PubMed Web of Science ®Google Scholar
• Salvi S, Barnes P. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009;14(9691):733–743.
   Web of Science ®Google Scholar
• Make B, Dutro M, Paulose-Ram R, et al. Undertreatment of COPD: a retrospective analysis of US managed care and Medicare patients. Int J Chron Obstruct Pulmon Dis. 2012;7:1–9.
   PubMed Web of Science ®Google Scholar
• Lindenauer P, Pekow P, Gao S, et al. Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 2006;144(12):894–903.
   PubMed Web of Science ®Google Scholar
• O’Donnell D, Aaron S, Bourbeau J, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease–2007 update. Can Respir J. 2007;14(suppl b):5B–32B.
   PubMed Web of Science ®Google Scholar
• Anzueto A, Leimer I, Kesten S. Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes. Int J Chron Obstruct Pulmon Dis. 2009;4:245–251.
   PubMedGoogle Scholar
• Soler-Cataluña J, Martínez-García M, Román Sánchez P, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925–931.
   PubMed Web of Science ®Google Scholar
• Jencks S, Williams M, Coleman E. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360(14):1418–1428.
   PubMed Web of Science ®Google Scholar
• McGhan R, Radcliff T, Fish R, et al. Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest. 2007;132(6):1748–1755.
   PubMed Web of Science ®Google Scholar
• Shah T, Press V, Huisingh-Scheetz M, et al. COPD readmissions: addressing COPD in the era of value-based health care. Chest. 2016;150(4):916–926.
   PubMed Web of Science ®Google Scholar
• Ford E, Murphy L, Khavjou O, et al. Total and state-specific medical and absenteeism costs of COPD among adults aged ≥18 years in the United States for 2010 and projections through 2020. Chest. 2015;147(1):31–45.
   PubMed Web of Science ®Google Scholar
• Han M, Martinez C, Au D, et al. Meeting the challenge of COPD care delivery in the USA: a multiprovider perspective. Lancet. 2016;4(6):473–526.
   Web of Science ®Google Scholar
• Mannino D. Counting costs in COPD from the Department of Preventive Medicine and Environmental Health, University of Kentucky College of Public Health: what do the numbers mean? Chest. 2015;147(1):3–5.
   PubMed Web of Science ®Google Scholar
• Chuang C. Transition of patients with COPD across different care settings: challenges and opportunities for hospitalists. Hosp Pract. 2012;40(1):176–185.
   Google Scholar
• Chuang C, Levine SH, Rich J. Enhancing cost-effective care with a patient-centric coronary obstructive pulmonary disease program. Popul Health Manag. 2011;14(3):133–136.
   PubMed Web of Science ®Google Scholar
• Dewan N, Rice K, Caldwell M, et al. Economic evaluation of a disease management program for chronic obstructive pulmonary disease. COPD. 2011;8(3):153–159.
   PubMedGoogle Scholar
• Koff P, Jones R, Cashman J, et al. Proactive integrated care improves quality of life in patients with COPD. Eur Respir J. 2009;33(5):1031–1038.
   PubMed Web of Science ®Google Scholar
• Nici L, ZuWallack R. Integrated care in chronic obstructive pulmonary disease and rehabilitation. COPD. 2018;15(3):223–230.
   PubMedGoogle Scholar
• Qureshi H, Sharafkhaneh A, Hanania N. Chronic obstructive pulmonary disease exacerbations: latest evidence and clinical implications. Ther Adv Chronic Dis. 2014;5(5):212–227.
   PubMedGoogle Scholar
• Miravitlles M, Moragas A, Hernández S, et al. Is it possible to identify exacerbations of mild to moderate COPD that do not require antibiotic treatment? Chest. 2013;144(5):1571–1577.
   PubMed Web of Science ®Google Scholar
• Beghé B, Verduri A, Roca M, et al. Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD. Eur Respir J. 2013;41(4):993–995.
   PubMed Web of Science ®Google Scholar
• Blackstock F, ZuWallack R, Nici L, et al. Why don’t our patients with chronic obstructive pulmonary disease listen to us? The enigma of nonadherence. Ann Am Thorac Soc. 2016;13(3):317–323.
   PubMed Web of Science ®Google Scholar
• Loh C, Peters S, Lovings T, et al. Suboptimal inspiratory flow rates are associated with chronic obstructive pulmonary disease and all-cause readmissions. Ann Am Thorac Soc. 2017;14(8):1305–1311.
   PubMed Web of Science ®Google Scholar
• Celli B, MacNee W, Agusti A. ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23(6):932–946.
   PubMed Web of Science ®Google Scholar
• Crisafulli E, Barbeta E, Ielpo A, et al. Management of severe acute exacerbations of COPD: an updated narrative review. Multidiscip Respir Med. 2018;13(1):36.
   PubMedGoogle Scholar
• Cazzola M, Bettoncelli G, Sessa E, et al. Prevalence of comorbidities in patients with chronic obstructive pulmonary disease. Respiration. 2010;80(2):112–119.
   PubMed Web of Science ®Google Scholar
• Rutten F, Cramer M, Lammers J, et al. Heart failure and chronic obstructive pulmonary disease: an ignored combination? Eur J Heart Fail. 2006;8(7):706–711.
   PubMed Web of Science ®Google Scholar
• Batterink J, Dahri K, Aulakh A, et al. Evaluation of the use of inhaled medications by hospital inpatients with chronic obstructive pulmonary disease. Can J Hosp Pharm. 2012;65(2):111–118.
   PubMedGoogle Scholar
• Press V, Arora V, Shah L, et al. Misuse of respiratory inhalers in hospitalized patients with asthma or COPD. J Gen Intern Med. 2011;26(6):635–642.
   PubMed Web of Science ®Google Scholar
• Taffet G, Donohue J, Altman P. Considerations for managing chronic obstructive pulmonary disease in the elderly. Clin Interv Aging. 2014;9:23–30.
   PubMed Web of Science ®Google Scholar
• Yawn B, Colice G, Hodder R. Practical aspects of inhaler use in the management of chronic obstructive pulmonary disease in the primary care setting. Int J Chron Obstruct Pulmon Dis. 2012;7:495–502.
   PubMed Web of Science ®Google Scholar
• Bourbeau J, Bartlett S. Patient adherence in COPD. Thorax. 2008;63(9):831–838.
   PubMed Web of Science ®Google Scholar
• Lindenauer P, Shieh M, Pekow P, et al. Use and outcomes associated with long-acting bronchodilators among patients hospitalized for chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2014;11(8):1186–1194.
   PubMedGoogle Scholar
• Petite S, Murphy J. Evaluation of bronchodilator use during chronic obstructive pulmonary disease exacerbation inpatient admissions. Hosp Pharm. 2019;54(2):112–118.
   PubMed Web of Science ®Google Scholar
• Walters J, Tan D, White C, et al. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2014;1(9):CD001288.
   Google Scholar
• Leuppi J, Schuetz P, Bingisser R, et al. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA. 2013;309(21):2223–2231.
   PubMed Web of Science ®Google Scholar
• Woods J, Wheeler J, Finch C, et al. Corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2014;9:421–430.
   PubMed Web of Science ®Google Scholar
• Lindenauer P, Pekow, P, Lahti, M, et al. Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease. JAMA. 2010;303(23):2359–2367.
   PubMed Web of Science ®Google Scholar
• Quon B, Gan W, Sin D. Contemporary management of acute exacerbations of COPD: a systematic review and metaanalysis. Chest. 2008;133(3):756–766.
   PubMed Web of Science ®Google Scholar
• Vollenweider D, Jarrett H, Steurer-Stey C, et al. Antibiotics for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2012;12:CD010257.
   PubMedGoogle Scholar
• El Moussaoui R, Roede B, Speelman P, et al. Short-course antibiotic treatment in acute exacerbations of chronic bronchitis and COPD: a meta-analysis of double-blind studies. Thorax. 2008;63(5):415–422.
   PubMed Web of Science ®Google Scholar
• Falagas M, Avgeri S, Matthaiou D, et al. Short- versus long-duration antimicrobial treatment for exacerbations of chronic bronchitis: a meta-analysis. J Antimicrob Chemother. 2008;62(3):442–450.
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Anzueto A. Chronic respiratory infection in patients with chronic obstructive pulmonary disease: what is the role of antibiotics? Int J Mol Sci. 2017;18(7):1344.
   PubMed Web of Science ®Google Scholar
• Rello J. Importance of appropriate initial antibiotic therapy and de-escalation in the treatment of nosocomial pneumonia. Eur Respir Rev. 2007;16(103):33–39.
   Google Scholar
• Nebraska Medicine. Antibiotic guidance for treatment of acute exacerbations of COPD (AECOPD) in adults. cited Jan 26 2021. https://www.nebraskamed.com/sites/default/files/documents/for-providers/asp/COPD_pathway2018_Update.pdf
   Google Scholar
• Putcha N, Wise R. Medication regimens for managing COPD exacerbations. Respir Care. 2018;63(6):773–782.
   PubMed Web of Science ®Google Scholar
• Sethi S. Infection as a comorbidity of COPD. Eur Respir J. 2010;35(6):1209–1215.
   PubMed Web of Science ®Google Scholar
• Usmani O, Lavorini F, Marshall J, et al. Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes. Respir Res. 2018;19(1):10.
   PubMed Web of Science ®Google Scholar
• Silver P, Kollef M, Clinkscale D, et al. A respiratory therapist disease management program for subjects hospitalized with COPD. Respir Care. 2017;62(1):1–9.
   PubMed Web of Science ®Google Scholar
• Smith A, Palmer V, Farhat N, et al. Hospital-based clinical pharmacy services to improve ambulatory management of chronic obstructive pulmonary disease. J Pharm Technol. 2017;33(1):8–14.
   Web of Science ®Google Scholar
• Yu A, Guérin A, Ponce de Leon D, et al. Therapy persistence and adherence in patients with chronic obstructive pulmonary disease: multiple versus single long-acting maintenance inhalers. J Med Econ. 2011;14(4):486–496.
   PubMedGoogle Scholar
• Sanders M. Guiding inspiratory flow: development of the In-Check DIAL G16, a tool for improving inhaler technique. Pulm Med. 2017;2017:1495867.
   PubMed Web of Science ®Google Scholar
• Ghosh S, Pleasants R, Ohar J, et al. Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD. Int J Chron Obstruct Pulmon Dis. 2019;14:585–595.
   PubMed Web of Science ®Google Scholar
• Janssens W, VandenBrande P, Hardeman E, et al. Inspiratory flow rates at different levels of resistance in elderly COPD patients. Eur Respir J. 2008;31(1):78–83.
   PubMed Web of Science ®Google Scholar
• Mahler D. Peak inspiratory flow rate as a criterion for dry powder inhaler use in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2017;14(7):1103–1107.
   PubMed Web of Science ®Google Scholar
• Mahler D, Waterman L, Gifford A. Prevalence and COPD phenotype for a suboptimal peak inspiratory flow rate against the simulated resistance of the Diskus® dry powder inhaler. J Aerosol Med Pulm Drug Deliv. 2013;26(3):174–179.
   PubMed Web of Science ®Google Scholar
• Sharma G, Mahler D, Mayorga V, et al. Prevalence of low peak inspiratory flow rate at discharge in patients hospitalized for COPD exacerbation. Chronic Obstr Pulm Dis. 2017;4(3):217–224.
   PubMed Web of Science ®Google Scholar
• MacNee W. Pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2(4):258–266.
   PubMedGoogle Scholar
• Tønnesen P. Smoking cessation and COPD. Eur Respir Rev. 2013;22(127):37–43.
   PubMedGoogle Scholar
• Kopsaftis Z, Wood-Baker R, Poole P. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2018;6:CD002733.
   PubMed Web of Science ®Google Scholar
• Nichols M, Andrew M, Hatchette T, et al. Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: a pooled analysis from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS Network). Vaccine. 2018;36(16):2166–2175.
   PubMed Web of Science ®Google Scholar
• Walters J, Tang J, Poole P, et al. Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2017;1:CD001390.
   PubMed Web of Science ®Google Scholar
• Cornelison S, Pascual R. Pulmonary rehabilitation in the management of chronic lung disease. Med Clin North Am. 2019;103(3):577–584.
   PubMed Web of Science ®Google Scholar
• Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13–64.
   PubMed Web of Science ®Google Scholar
• McCarthy B, Casey D, Devane D, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015(2):CD003793.
   PubMed Web of Science ®Google Scholar
• Cavaillès A, Brinchault-Rabin G, Dixmier A, et al. Comorbidities of COPD. Eur Respir Rev. 2013;22(130):454–475.
   PubMedGoogle Scholar
• Chatila W, Thomashow B, Minai O, et al. Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008;5(4):549–555.
   PubMedGoogle Scholar
• Finks S, Rumbak M, Self T. Treating hypertension in chronic obstructive pulmonary disease. N Engl J Med. 2020;382(4):353–363.
   PubMed Web of Science ®Google Scholar
• Morgan A, Zakeri R, Quint J. Defining the relationship between COPD and CVD: what are the implications for clinical practice? Ther Adv Respir Dis. 2018;12:1753465817750524.
   Web of Science ®Google Scholar
• Marin J, Soriano J, Carrizo S, et al. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am J Respir Crit Care Med. 2010;182(3):325–331.
   PubMed Web of Science ®Google Scholar
• Yohannes A, Alexopoulos G. Depression and anxiety in patients with COPD. Eur Respir Rev. 2014;23(133):345–349.
   PubMedGoogle Scholar
• Landers A, Wiseman R, Pitama S, et al. Severe COPD and the transition to a palliative approach. Breathe (Sheff). 2017;13(4):310–316.
   PubMedGoogle Scholar
• Mansukhani R, Bridgeman M, Candelario D, et al. Exploring transitional care: evidence-based strategies for improving provider communication and reducing readmissions. P T. 2015;40(10):690–694.
   PubMedGoogle Scholar
• Jalota L, Jain V. Action plans for COPD: strategies to manage exacerbations and improve outcomes. Int J Chron Obstruct Pulmon Dis. 2016;2(11):1179–1188.
   Google Scholar
• Donaldson G, Wedzicha J. COPD exacerbations. 1: epidemiology. Thorax. 2006;61(2):164–168.
   PubMed Web of Science ®Google Scholar
• Gruffydd-Jones K, Langley-Johnson C, Dyer C, et al. What are the needs of patients following discharge from hospital after an acute exacerbation of chronic obstructive pulmonary disease (COPD)? Prim Care Respir J. 2007;16(6):363–368.
   PubMedGoogle Scholar
• Coleman E. The Care Transitions Program. What will it take to ensure high quality transitional care? 2011 cited Feb 10 2021. http://www.caretransitions.org
   Google Scholar
• García-Fernández F, Arrabal-Orpez M, Rodríguez-Torres Mdel C, et al. Effect of hospital case-manager nurses on the level of dependence, satisfaction and caregiver burden in patients with complex chronic disease. J Clin Nurs. 2014;23(19–20):2814–2821.
   PubMed Web of Science ®Google Scholar
• Kripalani S, LeFevre F, Phillips C, et al. Deficits in communication and information transfer between hospital-based and primary care physicians: implications for patient safety and continuity of care. JAMA. 2007;297(8):831–841.
   PubMed Web of Science ®Google Scholar
• Pham H, Grossman J, Cohen G, et al. Hospitalists and care transitions: the divorce of inpatient and outpatient care. Health Aff (Millwood). 2008;27(5):1315–1327.
   PubMed Web of Science ®Google Scholar
• Burke R, Ryan P. Postdischarge clinics: hospitalist attitudes and experiences. J Hosp Med. 2013;8(10):578–581.
   PubMed Web of Science ®Google Scholar
• Piquet J, Chavaillon J, David P, et al. High-risk patients following hospitalisation for an acute exacerbation of COPD. Eur Respir J. 2013;42(4):946–955.
   PubMed Web of Science ®Google Scholar
• Sanchez G, Douglass M, Mancuso M. Revisiting project re-engineered discharge (RED): the impact of a pharmacist telephone intervention on hospital readmission rates. Pharmacotherapy. 2015;35(9):805–812.
   PubMed Web of Science ®Google Scholar
• Harrison J, Auerbach A, Quinn K, et al. Assessing the impact of nurse post-discharge telephone calls on 30-day hospital readmission rates. J Gen Intern Med. 2014;29(11):1519–1525.
   PubMed Web of Science ®Google Scholar